KRAS and neoplasm: We further detected KRAS mutations in 71 surrounding endometrial tissues of PPE, which included 48 non-hyperplastic, 7 concurrent hyperplasia, and 16 concurrent neoplasia (11 EAH and 5 carcinoma) tissues.